Clinical trial
18F-meta-fluorobenzylguanidine Cardiac Imaging for Evaluation of Chronic Heart Failure
NCT06149195 is registered in ClinicalTrials.gov with Sichuan Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 18F-meta-fluorobenzylguanidine Cardiac Imaging for Evaluation of Chronic Heart Failure
- Lead sponsor
- Sichuan Provincial People's Hospital
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- January 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rest gated myocardial perfusion imaging in heart failure